244 related articles for article (PubMed ID: 32561852)
21. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
[TBL] [Abstract][Full Text] [Related]
23. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
24. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk.
Wan W; Xiao W; Pan W; Chen L; Liu Z; Xu J
Cancer Chemother Pharmacol; 2022 Mar; 89(3):401-411. PubMed ID: 35171349
[TBL] [Abstract][Full Text] [Related]
25. Nanoformulation of Apolipoprotein E3-Tagged Liposomal Nanoparticles for the co-Delivery of KRAS-siRNA and Gemcitabine for Pancreatic Cancer Treatment.
Wang F; Zhang Z
Pharm Res; 2020 Nov; 37(12):247. PubMed ID: 33216236
[TBL] [Abstract][Full Text] [Related]
26. Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.
Santoro R; Zanotto M; Simionato F; Zecchetto C; Merz V; Cavallini C; Piro G; Sabbadini F; Boschi F; Scarpa A; Melisi D
Mol Cancer Ther; 2020 Jan; 19(1):247-257. PubMed ID: 31562256
[TBL] [Abstract][Full Text] [Related]
27. Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.
Mukhopadhyay S; Goswami D; Adiseshaiah PP; Burgan W; Yi M; Guerin TM; Kozlov SV; Nissley DV; McCormick F
Cancer Res; 2020 Apr; 80(8):1630-1643. PubMed ID: 31911550
[TBL] [Abstract][Full Text] [Related]
28. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
Sarkhosh-Inanlou R; Imani M; Sam MR
Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
[TBL] [Abstract][Full Text] [Related]
29. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
Santoro R; Zanotto M; Carbone C; Piro G; Tortora G; Melisi D
Anticancer Res; 2018 Apr; 38(4):1937-1946. PubMed ID: 29599309
[TBL] [Abstract][Full Text] [Related]
30. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ
Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103
[TBL] [Abstract][Full Text] [Related]
31. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M
Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967
[TBL] [Abstract][Full Text] [Related]
32. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
Sun Y; Peng W; He W; Luo M; Chang G; Shen J; Zhao X; Hu Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):166. PubMed ID: 30041673
[TBL] [Abstract][Full Text] [Related]
33. Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.
Ryu WJ; Han G; Lee SH; Choi KY
Biochem Biophys Res Commun; 2021 Apr; 549():40-46. PubMed ID: 33662667
[TBL] [Abstract][Full Text] [Related]
34. KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.
Kang YW; Lee JE; Jung KH; Son MK; Shin SM; Kim SJ; Fang Z; Yan HH; Park JH; Han B; Cheon MJ; Woo MG; Lim JH; Kim YS; Hong SS
Cancer Lett; 2018 Dec; 438():174-186. PubMed ID: 30217561
[TBL] [Abstract][Full Text] [Related]
35. Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis.
Shen H; Yang N; Truskinovsky A; Chen Y; Mussell AL; Nowak NJ; Kobzik L; Frangou C; Zhang J
Mol Cancer Res; 2019 Jan; 17(1):250-262. PubMed ID: 30237296
[TBL] [Abstract][Full Text] [Related]
36. Isoprenylcysteine carboxy methyltransferase (ICMT) is associated with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor.
Borini Etichetti C; Di Benedetto C; Rossi C; Baglioni MV; Bicciato S; Del Sal G; Menacho-Marquez M; Girardini J
J Biol Chem; 2019 Mar; 294(13):5060-5073. PubMed ID: 30655292
[TBL] [Abstract][Full Text] [Related]
37. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
Wang MT; Fer N; Galeas J; Collisson EA; Kim SE; Sharib J; McCormick F
Nat Commun; 2019 Jul; 10(1):3055. PubMed ID: 31296870
[TBL] [Abstract][Full Text] [Related]
38. Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation.
Lau HY; Wang M
Small GTPases; 2020 Jul; 11(4):271-279. PubMed ID: 29261009
[TBL] [Abstract][Full Text] [Related]
39. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
40. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Viale A; Pettazzoni P; Lyssiotis CA; Ying H; Sánchez N; Marchesini M; Carugo A; Green T; Seth S; Giuliani V; Kost-Alimova M; Muller F; Colla S; Nezi L; Genovese G; Deem AK; Kapoor A; Yao W; Brunetto E; Kang Y; Yuan M; Asara JM; Wang YA; Heffernan TP; Kimmelman AC; Wang H; Fleming JB; Cantley LC; DePinho RA; Draetta GF
Nature; 2014 Oct; 514(7524):628-32. PubMed ID: 25119024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
